SCHEMBL6565892

SCHEMBL6565892

COC(=O)c1cc(N)ccc1OC(c1ccccc1)c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.44
TDO2 P48775 2/20 0.44
IDO2 Q6ZQW0 2/20 0.44
GAA P10253 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 3/20 0.39
HPGD P15428 1/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
CASR P41180 1/20 0.38
RORC P51449 2/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CFTR P13569 1/20 0.37
ABL1 P00519 1/20 0.36
CTSA P10619 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567929 0.93 ABL1 (0.40) IDO1TDO2IDO2GAAMEN1
SCHEMBL6567926 0.91 HPGD (0.42) IDO1TDO2IDO2GAAMEN1
SCHEMBL6566010 0.90 IDO1 (0.48) IDO1TDO2GAAMEN1KMT2A
SCHEMBL6567751 0.89 CFTR (0.42) GAAKDM4ELMNAHPGDHTT
SCHEMBL6714679 0.88 IDO1 (0.48) IDO1TDO2IDO2GAAMEN1
SCHEMBL6564533 0.88 GAA (0.48) GAAMEN1KMT2AHSD17B10KDM4E
SCHEMBL6565999 0.86 IDO1 (0.43) IDO1TDO2GAAMEN1KMT2A
SCHEMBL6565805 0.86 ABL1 (0.44) IDO1TDO2GAAMEN1KMT2A
SCHEMBL6564515 0.85 IDO1 (0.46) IDO1TDO2IDO2GAAMEN1
SCHEMBL6565855 0.84 ABL1 (0.42) GAAMEN1KMT2AHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 IDO1 953/4885TDO2 675/4885IDO2 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.